Xencor Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
XNCR$39.39+2.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(in thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Cash flows from operating activities | |||
| Consolidated net loss | $(236,540) | $(133,296) | $(55,181) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization | 12,107 | 11,498 | 8,799 |
| (Accretion of discount) amortization of premium on marketable debt securities | (16,044) | (13,635) | 127 |
| Stock-based compensation | 53,281 | 53,755 | 48,913 |
| Abandonment of capitalized intangible assets | 2,329 | 1,267 | 1,510 |
| Loss on disposal of assets | 1,577 | 1,379 | 145 |
| Gain on sale of available-for-sale marketable debt securities | (37) | — | — |
| Equity received in connection with license agreement | — | (10,000) | (5,397) |
| Change in fair value of equity securities | 31,422 | 395 | (23,434) |
| Impairment on equity securities | 20,430 | — | 138 |
| Noncash royalty revenue related to sale of future royalties | (66,906) | (14,575) | — |
| Noncash interest expense | 36,593 | 6,153 | — |
| Changes in operating assets and liabilities: | |||
| Accounts receivable | (32,673) | 19,833 | 37,387 |
| Interest receivable from marketable debt securities | (3,441) | (1,028) | (530) |
| Prepaid expenses and other assets | 159 | 5,103 | 634 |
| Income taxes | (4,484) | 13,633 | — |
| Accounts payable | 2,845 | 3,826 | (3,913) |
| Accrued expenses | (4,347) | 4,836 | (715) |
| Lease liabilities and ROU assets | 1,541 | 3,250 | 22,976 |
| Deferred revenue | — | (30,320) | (6,974) |
| Net cash (used in) provided by operating activities | (202,188) | (77,926) | 24,485 |
| Cash flows from investing activities | |||
| Proceeds from maturities of marketable debt securities available-for-sale | 565,358 | 693,090 | 306,607 |
| Proceeds from sale of marketable debt securities available-for-sale | 24,696 | — | — |
| Proceeds from sale of equity securities | 6,640 | — | — |
| Proceeds from sale of property and equipment | — | 1 | — |
| Purchase of marketable securities | (595,054) | (782,905) | (387,928) |
| Purchase of intangible assets | (3,415) | (2,803) | (4,910) |
| Purchase of property and equipment | (6,097) | (18,448) | (38,494) |
| Conversion of convertible note | — | — | 5,000 |
| Net cash used in investing activities | (7,872) | (111,065) | (119,725) |
| Cash flows from financing activities | |||
| Proceeds from issuance of common stock and pre-funded warrants | 201,256 | — | — |
| Common stock and pre-funded warrants issuance costs | (12,077) | — | — |
| Proceeds from issuance of common stock upon exercise of stock awards | 6,313 | 3,412 | 3,610 |
| Proceeds from issuance of common stock from Employee Stock Purchase Plan | 1,660 | 1,977 | 2,092 |
| Proceeds from sale of future royalties | — | 183,330 | — |
| Proceeds from non-controlling interest | — | 500 | — |
| Net cash provided by financing activities | 197,152 | 189,219 | 5,702 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | (12,908) | 228 | (89,538) |
| Cash, cash equivalents, and restricted cash, beginning of year | 54,170 | 53,942 | 143,480 |
| Cash, cash equivalents, and restricted cash, end of year | $41,262 | $54,170 | $53,942 |
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Supplemental disclosures of cash flow information | |||
| Cash paid for: | |||
| Interest | $33 | $22 | $13 |
| Taxes | 6,100 | — | 700 |
| Supplemental schedule of noncash activities | |||
| Net unrealized (loss) gain on marketable debt securities available-for-sale | $(1,954) | $8,243 | $(5,442) |
| Addition of right-of-use asset | 7,166 | 2,462 | 6,155 |
| Reconciliation of cash, cash equivalents, and restricted cash reported in the balance sheets | |||
| Cash and cash equivalents | 40,875 | $53,790 | $53,942 |
| Restricted cash | 387 | $380 | $— |
| Total cash, cash equivalents, and restricted cash shown in the statement of cash flows | $41,262 | $54,170 | $53,942 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.